OBJECTIVE: To estimate the clinical effects and cost-effectiveness of universal prenatal
hepatitis C screening, and to calculate potential life expectancy, quality of life, and health …

Objective To investigate the prevalence and risk factors associated with parental depressive
symptoms at neonatal intensive care unit (NICU) discharge and determine the relationships …

Background Mental health problems during and after pregnancy such as depression,
anxiety, post‐traumatic stress disorder (PTSD), or addiction are common and can have …

Objective: To compare the rate of mental disorders (ie, mood and anxiety, substance use,
psychotic disorders) and suicide attempts within the same group of women across the pre …

Objectives Anxiety and/or depression during pregnancy or year after childbirth is the most
common complication of childbearing. Economic evaluations of interventions for the …

BACKGROUND: Brexanolone injection (BRX) was approved by the FDA in 2019 for the
treatment of adult patients with postpartum depression (PPD), but its cost-effectiveness has …

The pharmaceutical industry is almost boundless in its ability to supply new drug therapies,
but how does one decide which are the best medicines to use within restricted budgets …

Background: The fast spread of COVID-19 can cause some psychological disorders for men.
One of the psychological disorders is paternal postpartum depression (PPD). The aim of the …

Objective This study presents national estimates on symptoms consistent with postpartum
anxiety (PPA) and postpartum depression (PPD) and the association between these …

Background Perinatal depression affects an estimated 1 in 5 women in North America
during the perinatal period, with annualized lifetime costs estimated at 20.6 …